An immunomodulating dipeptide, SCV-07, is a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2)

International Journal of Antimicrobial Agents

Volumn 32, Issue 3, 2008, Pages 262-266

  Rose II, William A ^a   Tuthill, Cynthia ^b   Pyles, Richard B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SciClone Pharmaceuticals Inc   (United States)

Author keywords

Guinea pig; HSV 2; Immunomodulating dipeptide; Recurrent genital disease; SCV 07; Therapeutic

Indexed keywords

ACICLOVIR; GAMMA DEXTRO GLUTAMYL TRYPTOPHAN; IMMUNOMODULATING AGENT; SCV 07; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENITAL HERPES; GUINEA PIG; HERPES SIMPLEX VIRUS 2; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; DIPEPTIDES; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; GUINEA PIGS; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; RECURRENCE; TREATMENT OUTCOME;

EID: 49749130822     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.04.010     Document Type: Article

References (15)

1. Spruance S., Aoki F.Y., Tyring S., Stanberry L., Whitley R., and Hamed K. Short-course therapy for recurrent genital herpes and herpes labialis. J Fam Pract 56 (2007) 30-36
2. Corey L., and Ashley R. Prevention of herpes simplex virus type 2 transmission with antiviral therapy. Herpes 11 Suppl. 3 (2004) 170A-174A
3. Lingappa J.R., and Celum C. Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection. Drugs 67 (2007) 155-174
4. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 11 Suppl. 1 (2004) 24A-35A
5. Pereira D.B., Antoni M.H., Danielson A., Simon T., Efantis-Potter J., Carver C.S., et al. Stress as a predictor of symptomatic genital herpes virus recurrence in women with human immunodeficiency virus. J Psychosom Res 54 (2003) 237-244
6. Wardowska A., Dzierzbicka K., Trzonkowski P., and Mysliwski A. Immunomodulatory properties of new conjugates of muramyl dipeptide and nor-muramyl dipeptide with retro-tuftsin (Arg-Pro-Lys-Thr-OMe). Int Immunopharmacol 6 (2006) 1560-1568
7. Sidwell R.W., Smee D.F., Huffman J.H., Bailey K.W., Warren R.P., Burger R.A., et al. Antiviral Res 26 (1995) 145-159
8. Krivorutchenko Y.L., Andronovskaja I.B., Hinkula J., Krivoshein Y.S., Ljungdahl-Stahle E., Pertel S.S., et al. Vaccine 15 (1997) 1479-1486
9. Simbirtsev A., Kolobov A., Zabolotnych N., Pigareva N., Konusova V., Kotov A., et al. Russ J Immunol 8 (2003) 11-22
10. Bernstein D.I., Stanberry L.R., Harrison C.J., Kappes J.C., and Myers M.G. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir. J Gen Virol 67 (1986) 1601-1612
11. Stanberry L.R., Kern E.R., Richards J.T., Abbott T.M., and Overall Jr. J.C. Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J Infect Dis 146 (1982) 397-404
12. Stanberry L.R., Kern E.R., Richards J.T., and Overall Jr. J.C. Recurrent genital herpes simplex virus infection in guinea pigs. Intervirology 24 (1985) 226-231
13. Pyles R.B., Higgins D., Chalk C., Zalar A., Eiden J., Brown C., et al. J Virol 76 (2002) 11387-11396
14. Bourne N., Milligan G.N., Stanberry L.R., Stegall R., and Pyles R.B. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected. J Infect Dis 192 (2005) 2117-2123
15. Tuthill C, Vemuri S, Rios I, McMinn V, Verjee S, Rudolph A. Oral bioavailability of a dipeptide: SCV-07. In: American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference, 26-28 June 2007, San Diego, CA.